MBX Q1 2026 Earnings Narrower Than Expected Loss as Clinical Progress Continues Nuburu Q3 2023 Earnings Narrowing Losses Amid Operational Progress SUPN Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiencies Stock Declines Slightly FIS Q1 2026 Earnings EPS Surpasses Estimates by 46 Despite Minor Stock Dip KURA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Navigates Development YSG Q4 2025 Earnings EPS Surprise Boosts Investor Sentiment